Louisiana State Employees Retirement System increased its holdings in shares of Integer Holdings Corporation (NYSE:ITGR – Free Report) by 3.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 16,300 shares of the medical equipment provider’s stock after purchasing an additional 500 shares during the period. Louisiana State Employees Retirement System’s holdings in Integer were worth $2,004,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently added to or reduced their stakes in the company. Intech Investment Management LLC boosted its position in Integer by 92.8% during the 1st quarter. Intech Investment Management LLC now owns 22,682 shares of the medical equipment provider’s stock worth $2,677,000 after purchasing an additional 10,915 shares during the period. Dynamic Technology Lab Private Ltd purchased a new stake in Integer during the 1st quarter worth $916,000. Russell Investments Group Ltd. boosted its position in Integer by 14.7% during the 1st quarter. Russell Investments Group Ltd. now owns 6,749 shares of the medical equipment provider’s stock worth $796,000 after purchasing an additional 863 shares during the period. Wealth Enhancement Advisory Services LLC purchased a new stake in Integer during the 4th quarter worth $208,000. Finally, Teacher Retirement System of Texas purchased a new stake in Integer during the 1st quarter worth $579,000. 99.29% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on the stock. Wells Fargo & Company decreased their price target on shares of Integer from $152.00 to $132.00 and set an “overweight” rating for the company in a research report on Friday, July 25th. Truist Financial decreased their price objective on shares of Integer from $145.00 to $137.00 and set a “buy” rating for the company in a research report on Friday, July 25th. Raymond James Financial decreased their price objective on shares of Integer from $150.00 to $143.00 and set an “outperform” rating for the company in a research report on Friday, July 25th. Weiss Ratings reissued a “hold (c)” rating on shares of Integer in a research report on Wednesday. Finally, Wall Street Zen raised shares of Integer from a “hold” rating to a “buy” rating in a research report on Saturday, August 30th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Integer has a consensus rating of “Moderate Buy” and a consensus target price of $139.57.
Integer Stock Performance
Shares of Integer stock opened at $100.99 on Friday. The firm has a market cap of $3.54 billion, a PE ratio of 44.49, a price-to-earnings-growth ratio of 0.80 and a beta of 0.97. The firm’s 50-day simple moving average is $105.20 and its 200-day simple moving average is $113.58. The company has a debt-to-equity ratio of 0.72, a quick ratio of 2.18 and a current ratio of 3.41. Integer Holdings Corporation has a 1 year low of $99.54 and a 1 year high of $146.36.
Integer (NYSE:ITGR – Get Free Report) last issued its earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.02). The company had revenue of $476.00 million during the quarter, compared to analyst estimates of $464.37 million. Integer had a net margin of 4.61% and a return on equity of 12.27%. The business’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.30 EPS. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. Equities analysts forecast that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.
Integer Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
See Also
- Five stocks we like better than Integer
- Best Energy Stocks – Energy Stocks to Buy Now
- Bassett Furniture: Buy Now, Sit Back, and Collect Dividends
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- AST SpaceMobile’s Big Win: Shares Soar on New Deal With Verizon
- What Does a Stock Split Mean?
- Catch the Next Bitcoin Rally With These 3 ETFs
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.